Logo image
Se connecter
Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
Article de revue   Open Access   Avec comité de lecture

Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial

Solène Valéry, Noémie Simon-Tillaux, Gilles Devouassoux, Philippe Bonniaud, Antoine Beurnier, Amel Boudjemaa, Cécile Chenivesse, Arnaud Bourdin, Lisa Gauquelin, Sylvie Guillo, …
Journal of Allergy and Clinical Immunology, Vol.154(4)
05/06/2024
PMID: 38848878

Résumé

treatment switch severe asthma dupilumab benralizumab Mepolizumab Adult Female Middle Aged Anti-Asthmatic Agents Antibodies, Monoclonal Asthma Interleukin-5 Receptors, Interleukin-5 Treatment Failure Treatment Outcome Randomized Controlled Trials as Topic Humans Male

Fichiers et liens (2)

url
Find in HALAfficher
url
https://doi.org/10.1016/j.jaci.2024.05.023Afficher
Published (Version of record) Ouvrir

Indicateurs

1 Consultations de la notice

Détails

Logo image